Behandlung des akuten Hirninfarktes [Treatment of acute stroke -- an overview]


Autoria(s): Georgiadis D.; Michel P.; Bogousslavsky J.; Baumgartner R.W.
Data(s)

2003

Resumo

This paper provides an overview on the actual state of acute therapy in patients with ischemic stroke. The discussion focusses on intravenous and intraarterial thrombolysis, antithrombotic therapy, and the treatment of medical and neurological complications, and therapy recommendations are presented. Finally ongoing studies, particularly those concerning thrombolysis with glycoprotein IIb/IIIa receptor blockers and ultrasound-assisted thrombolysis, are presented.

Identificador

http://serval.unil.ch/?id=serval:BIB_618B725ABEA7

isbn:0040-5930

pmid:14579619

doi:10.1007/s10067-003-0732-3

isiid:000187058400028

Idioma(s)

de

Fonte

Therapeutische Umschau, vol. 60, no. 9, pp. 509-520

Palavras-Chave #Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal/therapeutic use; Anticoagulants/administration & dosage; Anticoagulants/therapeutic use; Aspirin/administration & dosage; Aspirin/therapeutic use; Brain Edema/therapy; Case-Control Studies; Cerebral Infarction/therapy; Clinical Trials, Phase IV as Topic; Double-Blind Method; Fibrinolytic Agents/administration & dosage; Fibrinolytic Agents/therapeutic use; Heparin/administration & dosage; Heparin/therapeutic use; Humans; Hypertension/complications; Hypertension/drug therapy; Immunoglobulin Fab Fragments/administration & dosage; Immunoglobulin Fab Fragments/therapeutic use; Intracranial Pressure; Intubation, Intratracheal; Ischemic Attack, Transient/drug therapy; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Placebos; Plasminogen Activators/administration & dosage; Plasminogen Activators/therapeutic use; Platelet Aggregation Inhibitors/administration & dosage; Platelet Aggregation Inhibitors/therapeutic use; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Respiration, Artificial; Stroke/complications; Stroke/drug therapy; Stroke/</QualifierName> <QualifierName MajorTopicYN="N">; Thrombolytic Therapy/contraindications; Ticlopidine/administration & dosage; Ticlopidine/analogs & derivatives; Time Factors; Tissue Plasminogen Activator/administration & dosage; Tissue Plasminogen Activator/therapeutic use; Tomography, X-Ray Computed
Tipo

info:eu-repo/semantics/review

article